Globenewswire
Search documents
Apollo Provides $1 Billion Hybrid Capital Solution to Aldar
Globenewswire· 2026-02-20 06:00
Core Insights - Apollo has invested $1 billion in subordinated hybrid notes issued by Aldar Properties, marking its fifth investment in the company since 2022, with total commitments reaching approximately $2.9 billion [1][2][3] - The investment aims to enhance Aldar's balance sheet flexibility and support its growth agenda, which includes landbank replenishment, portfolio expansion, and strategic acquisitions [2][3] - This transaction is noted as one of the largest foreign direct investments in Abu Dhabi's private sector and the largest corporate hybrid private placement in the region [3] Apollo's Investment Strategy - Apollo's ability to provide flexible capital solutions is highlighted, with a focus on meeting the needs of corporate clients and investors [3][4] - The investment reflects Apollo's commitment to the Abu Dhabi region and its confidence in Aldar's management and growth trajectory [3] Aldar's Business Overview - Aldar is a leading real estate developer and investment manager in Abu Dhabi, with a strategic landbank of 60 million square meters [7][8] - The company operates two core business segments: Aldar Development, which focuses on master development and community creation, and Aldar Investment, which manages a diversified portfolio of over AED 49 billion in income-generating real estate assets [8][9] Future Growth Potential - Aldar's develop-to-hold pipeline is valued at close to $5 billion, indicating significant growth potential through acquisitions and development projects [3][9] - The partnership with Apollo is expected to enhance Aldar's ability to capitalize on attractive opportunities in its core markets [3][9]
SIKA REPORTS FULL-YEAR 2025 RESULTS – EXECUTING PLAN TO ACCELERATE GROWTH
Globenewswire· 2026-02-20 04:00
Core Insights - Sika reported a decline in sales for 2025, with total revenues of CHF 11,201.3 million, down 4.8% year-on-year, but achieved a 0.6% growth in local currencies, indicating market share gains across all regions despite challenging conditions in the construction industry [3][5][19] - The company is implementing its Fast Forward program to enhance efficiency and innovation, expecting to generate annual savings of CHF 150 to 200 million by 2028, with a significant portion of these savings anticipated to take effect in 2026 [4][11][10] - Sika's EBITDA margin for 2025 was reported at 18.4%, with an adjusted margin of 19.2% after accounting for one-off costs related to the Fast Forward program, demonstrating strong core business profitability [4][5][17] Financial Performance - Sika's net profit for 2025 was CHF 1,045 million, a decrease of 16.2% from CHF 1,248 million in 2024, with diluted earnings per share falling to CHF 6.50 from CHF 7.76 [5][6][17] - Operating free cash flow was CHF 1,356 million, slightly down from CHF 1,403 million in 2024, but cash conversion improved to 12.1% of sales from 11.9% [5][6][17] - The company proposed an increase in the dividend to CHF 3.70 per share, reflecting a 2.8% year-on-year increase [5][13] Market Dynamics - In the EMEA region, Sika achieved a sales growth of 2.2% in local currencies, with particularly strong performance in the Middle East and Africa [7] - The Americas region also saw a 2.2% increase in sales in local currencies, although the second half of the year faced challenges due to a government shutdown affecting commercial construction [8] - The Asia/Pacific region experienced a decline of 5.3% in local currencies, primarily due to a significant drop in the Chinese construction business, although excluding this segment, the region recorded positive organic growth of 2.5% [9] Strategic Initiatives - The Fast Forward program aims to streamline operations and enhance digital transformation, with targeted structural adjustments in China and efficiency measures in other markets [10][11] - Sika is focused on sustainable performance, achieving a 6.1% reduction in Scope 1 and 2 GHG emissions and improvements in water discharge and waste management [12] - The company remains committed to its medium-term strategic targets for sustainable and profitable growth, with expectations of sales growth of 1% to 4% in local currencies for 2026 [15][16]
SIKA MELDET JAHRESERGEBNISSE 2025 – MASSNAHMEN ZUR BESCHLEUNIGUNG DES WACHSTUMS WERDEN UMGESETZT
Globenewswire· 2026-02-20 04:00
Core Insights - Sika reported a revenue of CHF 11,201.3 million for 2025, a decrease of 4.8% compared to 2024, but a 0.6% increase in local currencies, indicating market share gains despite challenging global conditions [3][4][19] - The company is implementing the "Fast Forward" program to enhance organizational agility, innovation, and efficiency, expecting a positive EBITDA effect of CHF 150 to 200 million in the coming years [2][11] - Sika anticipates a revenue growth of 3 to 6% in local currencies for 2026, despite a weaker first half of the year, with an expected EBITDA margin of 19.5 to 20.0% [2][18] Financial Performance - The material margin improved to 54.9% in 2025 from 54.5% in 2024, reflecting a strong focus on cost management and efficiency [4][5] - EBITDA for 2025 was CHF 2,064.7 million, down from CHF 2,269.5 million in 2024, with an EBITDA margin of 18.4%, which would be 19.2% when adjusted for one-time costs related to the Fast Forward program [4][5][19] - Net profit for 2025 was CHF 1,045.3 million, a decrease of 16.2% from CHF 1,247.6 million in 2024, with earnings per share dropping to CHF 6.50 from CHF 7.76 [6][19] Market Dynamics - Sika's largest region, EMEA, saw a revenue growth of 2.2% in local currencies, with strong performance in the Middle East and Africa [7] - In the Americas, revenue growth was also 2.2% in local currencies, impacted by a government shutdown affecting commercial construction [8] - The Asia-Pacific region experienced a decline of 5.3% in local currencies, primarily due to a significant drop in the Chinese construction market, although excluding this, the region showed positive organic growth of 2.5% [9] Strategic Initiatives - The Fast Forward program aims to streamline operations and enhance digital transformation, with expected annual savings of CHF 150 to 200 million starting from 2028, and CHF 80 million anticipated in 2026 [10][11] - Sika is committed to improving its ESG performance, achieving a 6.1% reduction in greenhouse gas emissions and a 14.1% decrease in accidents with lost time [12] Dividend and Governance - The Board of Directors proposed an increase in the gross dividend to CHF 3.70 per share, up 2.8% from the previous year [14] - New board members are proposed for election at the upcoming general meeting, with a focus on enhancing governance and strategic oversight [15]
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO
Globenewswire· 2026-02-20 03:28
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Inovio Pharmaceuticals securities between October 10, 2023, and December 26, 2025, of the April 7, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Inovio securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The deadline to move the Court to serve as lead plaintiff is April 7, 2026, with the lead plaintiff acting on behalf of other class members [2] Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3] Group 3: Case Background - Inovio Pharmaceuticals is a biotechnology company focused on DNA medicines for diseases like human papillomavirus (HPV) [4] - The lawsuit alleges that Inovio made false or misleading statements regarding the manufacturing of its CELLECTRA device and the prospects of its INO-3107 Biologics License Application (BLA) to the FDA [4] - It is claimed that the company overstated the regulatory and commercial prospects of INO-3107, leading to investor damages when the true information became public [4]
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - POM
Globenewswire· 2026-02-20 03:26
Core Viewpoint - Rosen Law Firm is reminding investors who purchased PomDoctor Ltd. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The class action lawsuit has been filed against PomDoctor Ltd. for misleading statements and fraudulent activities during the Class Period from October 9, 2025, to December 11, 2025 [4] - Investors who purchased PomDoctor securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][4] - The deadline to move the Court to serve as lead plaintiff is April 7, 2026, and a lead plaintiff acts on behalf of other class members [2] Group 2: Allegations Against PomDoctor - The lawsuit alleges that PomDoctor was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [4] - It is claimed that insiders used offshore accounts to facilitate the coordinated dumping of shares during a price inflation campaign [4] - The public statements made by PomDoctor omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3]
Snail Games 将携《ARK》系列最新进展及不断壮大的游戏产品阵容亮相 2026 年游戏开发者大会
Globenewswire· 2026-02-20 02:50
加利福尼亚州卡尔弗城, Feb. 20, 2026 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq:SNAL,以下简称 “Snail Games” 或 “公司”),今日宣布将参展于 2026 年 3 月 9 日至 13 日在加利福尼亚州旧金山举行的 2026 年游戏开发者大会 (GDC)。 作为开发商、发行商及技术领导者汇聚的行业顶级盛会之一,GDC 是推动协作、促进业务发展以及洞察互动娱乐未来趋势的关键活动。 Snail Games 参加 GDC 2026,体现了公司持续致力于加强全球开发者社区联系、推进长期战略增长计划的承诺。 大会期间,Snail Games 将公布新项目,并分享其不断扩大的游戏产品阵容的新动态,包括《ARK》系列的最新进展。 公司领导层及多个开发团队将亲临现场,与合作伙伴、投资者及媒体会面,探讨当前举措、发行机遇及拓展战略。 会面将聚焦于在互动娱乐生态内培育战略合作伙伴关系并推动可持续增长。 与会者欢迎莅临展览层第 1238 号 Snail Games 展位参观。 有意安排采访的媒体代表,请联系 press@ ...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Endeavor Group Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EDR
Globenewswire· 2026-02-20 02:10
Core Viewpoint - Rosen Law Firm is reminding sellers of Endeavor Group Holdings, Inc. Class A common stock about a class action lawsuit and the upcoming lead plaintiff deadline on March 18, 2026 [1]. Group 1: Class Action Details - Investors who sold Endeavor Class A common stock between January 15, 2025, and March 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 18, 2026 [3]. - The lawsuit seeks to recover damages for investors due to allegedly false and misleading statements in the January 15, 2025 Information Statement and related SEC filings [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The complaint alleges that the Information Statement misled investors regarding the true value of Endeavor's shares and failed to disclose executive earnings and conflicts of interest related to the merger [5].
EIS Approval for Patterson Lake South Project
Globenewswire· 2026-02-20 01:48
Core Viewpoint - Paladin Energy Ltd has received Ministerial approval for its Environmental Impact Statement (EIS) for the Patterson Lake South (PLS) Project, marking a significant regulatory milestone for the project [1][2]. Regulatory Approval - The Saskatchewan Minister of Environment has formally approved the EIS for the PLS Project, which is characterized as shallow and high grade [2]. - This approval follows the technical acceptance of the EIS in June 2025 and an extensive public review period from July to September 2025 [2]. Project Development - The Environmental Assessment approval is a prerequisite for obtaining necessary permits and licenses from provincial and federal authorities, which are essential for the construction and operation of the PLS Project [2]. - Paladin is actively collaborating with the Canadian Nuclear Safety Commission (CNSC) to advance the licensing process for the PLS Project at the federal level [3]. Government Support - Saskatchewan Premier Scott Moe expressed support for Paladin's sustainable development approach for the PLS Project, highlighting its importance to the province's energy sector [4]. - Minister of Environment Darlene Rowden emphasized the project's alignment with Saskatchewan's Growth Plan and its role as an energy supplier, noting the robust Environmental Assessment process it underwent [4]. Company Leadership - Paladin's Managing Director and CEO, Paul Hemburrow, stated that the approval reflects the company's commitment to sustainable and safe development, which is economically and strategically significant for Canada [4].
Blue Hat Interactive Entertainment Technology Announces Pricing of US$6.4 Million Public Offering
Globenewswire· 2026-02-20 01:15
Core Viewpoint - Blue Hat Interactive Entertainment Technology has announced a public offering of 32,000,000 Units at a price of US$0.20 per Unit, aiming to raise approximately US$6.4 million before expenses [1][3]. Offering Details - Each Unit consists of one ordinary share and one warrant, with the warrant initially exercisable for one ordinary share at an exercise price of US$0.20 [1][2]. - The warrants will expire one year from issuance and can be exercised immediately, with adjustments to the exercise price occurring on the 2nd and 5th trading days post-offering [2]. - The offering is expected to close on February 23, 2026, subject to customary closing conditions [3]. Underwriter Information - Maxim Group LLC is acting as the sole underwriter for the offering [5]. - The underwriter has a 15-day option to purchase up to 4,800,000 additional Units, which may include ordinary shares and/or warrants [4]. Company Background - Blue Hat was previously involved in communication services and is now expanding into commodity trading, aiming to become a leading intelligent commodity trader globally [8].
UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-20 01:13
Core Insights - AMN Healthcare Services, Inc. reported a fourth quarter revenue of $748 million, marking a 2% increase year-over-year, while the full year revenue decreased by 8% to $2.730 billion [3][15] - The company experienced a net loss of $7.7 million in Q4 2025, with an adjusted diluted EPS of $0.22, down 70% from the previous year [7][15] - The company is strategically positioned to capture market share in nurse and allied staffing, focusing on innovative workforce solutions amid industry challenges [5][6] Financial Performance - Q4 2025 revenue was $748.2 million, a 2% increase from Q4 2024, while full year revenue was $2,730.4 million, an 8% decrease from 2024 [3][15] - Gross profit for Q4 2025 was $195.1 million, down 11% year-over-year, with a gross margin of 26.1%, a decline of 370 basis points [3][12] - The company reported a net loss of $7.7 million for Q4 2025, compared to a net loss of $188 million in the same quarter last year [7][15] Segment Performance - The Nurse and Allied Solutions segment generated $491 million in revenue for Q4 2025, an 8% increase year-over-year, while the Physician and Leadership Solutions segment reported $170 million, down 2% year-over-year [9][10] - The Technology and Workforce Solutions segment saw a revenue decline of 18% year-over-year, totaling $88 million [11] - Labor disruption revenue contributed $124 million in Q4 2025, highlighting the impact of large labor disruption events [9] Operational Highlights - Cash flow from operations was $76 million for Q4 2025, with a total of $269 million for the full year [8][19] - The company reduced its debt by $75 million in Q4 2025, totaling a $285 million reduction for the year [8][19] - AMN Healthcare's strategic investments in technology and automation have improved fulfillment scalability and order fill rates [6] Future Outlook - For Q1 2026, consolidated revenue is projected to be between $1.225 billion and $1.240 billion, representing a year-over-year increase of 78-80% [21] - The Nurse and Allied Solutions segment is expected to see revenue growth of 137-139% compared to the prior year, driven by anticipated labor disruption revenue of approximately $600 million [21] - The company anticipates a gross margin of 23.5% to 24.0% for Q1 2026, reflecting ongoing efforts to improve operational efficiency [21]